EPA significantly improves anti-EGFR targeted therapy by regulating miR-378 expression in colorectal...
EPA significantly improves anti-EGFR targeted therapy by regulating miR-378 expression in colorectal cancer
About this item
Full title
Author / Creator
Publisher
Greece: Spandidos Publications UK Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Greece: Spandidos Publications UK Ltd
Subjects
More information
Scope and Contents
Contents
It is known that colorectal cancer (CRC) cells containing mutations of the genes KRAS and BRAF are predominate mechanisms causing resistance to epidermal growth factor receptor (EGFR) inhibitors, and commonly exhibit a lower expression of microRNA-378 (miR-378) when compared with the wild type. In the present study, the aim was to determine the pos...
Alternative Titles
Full title
EPA significantly improves anti-EGFR targeted therapy by regulating miR-378 expression in colorectal cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6176383
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6176383
Other Identifiers
ISSN
1792-1074
E-ISSN
1792-1082
DOI
10.3892/ol.2018.9408
